pre-miRNA Information | |
---|---|
pre-miRNA | hsa-mir-6818 |
Genomic Coordinates | chr22: 30007049 - 30007113 |
Description | Homo sapiens miR-6818 stem-loop |
Comment | None |
RNA Secondary Structure | ![]() |
Mature miRNA Information | |||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mature miRNA | hsa-miR-6818-5p | ||||||||||||||||||
Sequence | 6| UUGUGUGAGUACAGAGAGCAUC |27 | ||||||||||||||||||
Evidence | Experimental | ||||||||||||||||||
Experiments | Meta-analysis | ||||||||||||||||||
SNPs in miRNA |
|
||||||||||||||||||
Putative Targets |
Gene Information | |||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Gene Symbol | YOD1 | ||||||||||||||||||||
Synonyms | DUBA8, OTUD2, PRO0907 | ||||||||||||||||||||
Description | YOD1 deubiquitinase | ||||||||||||||||||||
Transcript | NM_018566 | ||||||||||||||||||||
Expression | |||||||||||||||||||||
Putative miRNA Targets on YOD1 | |||||||||||||||||||||
3'UTR of YOD1 (miRNA target sites are highlighted) |
>YOD1|NM_018566|3'UTR 1 CCTATGCATGAATGAGGGTTGAAGCCTACTACCTCACACATCCAGAAGGCTCTGGGTTTTCCAATAAGCTATGGTAACCC 81 TAAAGAACAAAGGATACAATGCTTGAACCATCCTTTTAACTTAAAACCACTAAGACACTGAAATTCCTTGTTAAGATTAA 161 AATTAGTGTGCAAGTTTACAGATGTGTGTCTACAGTGGTAAACTGTACATACATGCCTCTTTCTGCTGGAGTGACAGAAT 241 AGGTGATCCTTGCCACCTACTGACACTGACCTGAAGGTTGAGATTGAGTATTATAAACTAGCACCCAGCAGCTTTAACTT 321 GTAGAAGAAAGCATCACATTTTGGGTAATGTGGAAGGCCTCCTGTGAGTCCACTGGGCATACGATTGAGATTGAGTATTA 401 TAAACTAGCACCCAGCAGCTTTAACTTGTAGAAGAAAGCATCACATTTTGGGTAATGTGGAAGGCCTCCTGTGAGTCCAC 481 TGGACATTTACCACAGTGTCTCCAGTAACTGAGTCTTTTTAAAAACTCTGAATGAGTTAAGTTTCTAAATTATGAATTGA 561 TTCATCAAATGAAGATACTCAGAATTGTCCAAACTGATTTTATATTGCAATTTGGTAGACATTATAAATGTGTGCTTAAC 641 CACTGATAAGTACATCACAAGCAATTTTTACAGGGATGAGTCTCATCCTTGAGAATGTTATCACAAAACAGGAACTGATT 721 GTGCCCTGTTTAAGATCTCTAGCATATAAAACGTAGAATGTATGAGGGAATAGGTGCCTGAGCAGCTTCCTGAAGCTTTA 801 AAAGACCGTTGGCCTCGTGTTTTAATGCAATTCATGTATTGGTCTTTGTCACATTGGATAACATTTTAAAGTTAAGCAGG 881 GTACTTTTTTAATTGAAATTCCTTGAAATTCGAGTCCTCAGTTTTTTCTTCATTTGCGTAAAGTTTATCGGGGGGAATTT 961 AATTTTCTCAGCTTTTTGTTAAGAGCACTTCCTCCAAAAAATTTTTTTCAAGTAATAATGCTCTGCTTTGGGTTGGTTTT 1041 TGTAAGATTTTTTGCACACCTAAAGAGTGTTTGCTTTTGTGCTAGCCTTATCCCTCCACTAAAGTTATTTTAAATAATTT 1121 CACATTTCTGCAAATTAGCACTTTGCTTATCTGCAATCTTTTACTTTGATTTTTGAAGTTTTAAAGCAATTGGAGTAATA 1201 CTGTTGAATGAACTAGTTTCACTTCCAAAATAGAAAAAATTGTAAATCCTTGCCTTATGCAGCTTTCTCAGAATTCTGCT 1281 TCTTCCTAGTACTAGATGTGTAGCCATTTGCTTAGTGGACTAATCCGCAAGGCACACCCTCTAAAACTTAGCTTCACTAC 1361 AAGATCTTCCAGATAAAAGTTTTCTACCTCTTTTCTTAATTATTCTGATCAGGGATGCTAAATTATAATTTGTTATGTAT 1441 TATCTCACATAATGTGAAGAGGCTTAATGTGAAGTTTTGTTATTTTGGTCTCTTTTTTATTAAGTATCTCACTTAGAAAT 1521 TCAGTGGTATACTTTAAAGCACTTGGATCTTTTTCAGCATATCTGCCTAGCAAATGTTTTAAAATTGACATTTATTTTTA 1601 GCACTTTCACTTGGTGAAGGTGGCCATATAAAATTAAGGAACATTTGAACAATATAAGAGAAAAGAACTTTTAAGGAACA 1681 ATTCACAAAGTTTGTTTGAAATTGTCAGATGACATTTCTTGAGTACCTTTTGTGTGCATAGTTATTTTAGACAATATAAG 1761 CTGTTATGGTCAGCATAACTTAAAAGTGTTTAGTTTTCTATTTTACTGAGCCTTAAAAATAGCACTGATGAGCTTATGAT 1841 ACTTAATGTTTGGCAATCATAATGTGTTCAAATTAATGGGATTGAAAATCTCTCCACACCTGACTCTCATCTGATCTGGA 1921 TGGTTTTGGTTTTGTATCTTTTTTACTTCTCCCAGAAAATACTAAATTTAAAACTGTAAATTAAGAATATACCACTAGAT 2001 AACAATTATCAAATTGAGCTTTATGCATCATTACTCAGAAAGCTTGCCTTCCTTTCTTTGCTACTTCAGGACACAGAGTT 2081 GACATTTGCTTACTACAGCTTTAGATCTAGAAGTTTATTCGTGCAACAAATATTTATTGAGTAATTTATACTGTGCCAGG 2161 CATGTTTTGATATGTTTCTGTCATATGTTTTGATATGTTCCAACATAAGTTTCTGTCACTTTATATTCAGTATATATTTT 2241 CTACAGTGGGTAAATTTAACAAATGGAAAGGAATAGAACACTGATATTTTACAGAATTAAACCCCTTCATTGTAAGGGCT 2321 TTGTTTACATATTAAGTGTCAAGTATTTATTCAGGGGATCTTATTTCATTGTATTTTATCTGTTATCTAGGTTGTCCATT 2401 TACCGGTTGGACACTGATACTCTGTCAAATTCCTTTCAAAAATGACTCTTTAGTCTGCTGAAATTTAGCACTAGTACTTT 2481 AGTGTTCTGATCCTGGAAAATTCAAGGTGAAGCTTTATTTGTGGACCATCTGATTTAATTATTGAGGATTAAAAACCTAA 2561 ACCTTTGCTCATTCTAAACTCAAGCTTTTAAGCCTCACAGAATTTACAGGGGTTTGCTTTTTGTTTGTTTGTTTTTTCAT 2641 TTTTTACTGTGCTTATTAAACTCTTGGAATTAGTTATTAAAGGGAGTAAATTCTCATCTTGGGAATTTTGAAAATCTATG 2721 GACTTACAACTTTCAGGAGGATTAAATGTCTTAAGTTTTGTACTAGAGCAGAATGAAATCTTTCCTATTCATTGAGTTTT 2801 TGCCTGCCATAGAGGAATTTTTTTAAAAATTAAAATGACAGTTTATATTAGTGGCAAAGTGAATAAAGACCTCACTTTCC 2881 CACCCCACCCTTCTTCCTTTCTCTTACTTTTCTTTGGATTAAAGGTCAGGTGTAGTACTATGAAGATTCACTCCTGAATA 2961 AAGTGATTTCAGAAGCTAAAATTTAACATACCTGGAAATTTTGTGATGTGTTAGCCAAGTGAAGACATTAGTGTGTTCCA 3041 TCTTTTGCTAATGGTTCATGGTTGATTTCTTCATTGTTTCCCATGAAATTAGCATAGTCAAGTGGTACCCTTGACGCTTG 3121 ACTGCTGGTCAGTTTGACCCTGTTTTTAACAACTAATGTAGTCATGCCGCTTGATTATTCCATGAAGTCCCAGCAAAATA 3201 ATAATGAGGAATTAACTAACATTATGTTATCTATCTAATTTGTCTGTGTCCCTAAATGCCCATGCCTAACTTGCTTCTCT 3281 AGTTTATTCCTTCTGTGGAGGGATTAAAACGTGGGTGTTGCAAGTTGCCCTAAGCTAAACATAGTTTTCTTACATCTTTT 3361 TGGGAAAAAAAATGGAATGGGAAGTATGCAAGATTAAGCAAGAGTGATTTTTTTTTTTTTTTGACAAATCAGGTGGCCTT 3441 CCTAAACATACTAAGAATTATGTTCTTTCATGTGTGGAGACACATTTGTTTGCAGCACTTTAAAAAATATATATGGAATA 3521 AAAGTTTACATGTTGGCCCTCTAGGGATCTAATTAAGGACATTAAAGTACAATTCTTGAGCTACTAACCATCAGCTCTTC 3601 TTAATCAAAGATTGCCATCAGTGTAGAGTGTATCTATTGGCACAACATTCTGGTGTTTTGATAACAGTAGAACTCAATTT 3681 CAGTAACTATTAGGAGCATGGTCTGTGCCCTAGCATTAAAAATGTTACTTATTATTATGTGAATATCTTGTATTATTATA 3761 CAATGCAGTATTCAAATTTGTCCTTGTAGTGCAGAGATGACTGATAATTTCTAAAAGATTCGATCCTTAAAACTTGTTTC 3841 CAAGCAGACTTATAAGGAAGCTGATTTTTGAGTCAGAGGCCTTAAACGTGTCATATACAAGTGGCATCATTTTAAGTCCA 3921 AAGTGAAACACTTGATTTGAATAAGCTAGTTTATAAACTAAAGCTGTTTTCTTATGTTACAGTATTTCAGCACATTTCAT 4001 TCCACATAAAAAGAATATTAAGTGTCCCTGGTTGTGGGAGAGTGTTTATTTTTCTCAAAATTATCTAGCATTTTGCTTAC 4081 AGTGCTTTGAATGTTTGACTTAAAATTATTATTGATGTTGAATTGTAGGGTGCTGATTTAGGTCTTGATTCATACACATT 4161 TAAAGGAGGTTGGTAACCCCCTCATGGTAGAGTGAAGGGAGAAAAGGGCCAAGAAGACAAAGTACCACTGATAAAGAAGA 4241 GATTGTCAAATAGATGCATTCCTAGTCATGAATTACCCTTTTCCAAACATTTTTAAAGCAATGCCTTTGTGTCAACTCAA 4321 CCCTTCTTCCCCATTTCTTGTCATAGAATGTAGCATGGCCATAGGTGAAAAAGCTTATCATTAAAGTATGAAACCATGAA 4401 TTATAAGCATTTTGCCATGATGCCCTTTTATACATATGTTTTTAAAAGTACTAACCAACATATAGGAGTTTAGGAATGGT 4481 GAAGATATAATTTGATTAAGTTGTAGGTAAACAGAAAGGATCATCTTAGGCTCAGAATTTCTAATATGATTACATGAGTC 4561 TACTTTATAAACTGGTATAGGCTATGTAATTAGCCCGTAAGTTACTTAAAGGACCAGGGGACCTAATTTTTGTCAGTTTT 4641 CCAGTCACATTGGTGCCATTCAGGACTCCAGCTGTTTACAGGAAATATGTACTTAGCAGAATAGTATTTTTCCTTGAAAA 4721 AAATTTGAATTCAGCCTAAATACAGAATGAATATGAATAGTTTGTGAAAAGGGTTAGAGAACAACAATATTCCTATAGTT 4801 TCTGTATTAATGCAGTAGAGACAGAGGTTCCTAACGCAAAAAGAAAACCACAAGTAAAGACCGTCAAATTAGAGCTTTAG 4881 AATATGACTTGAAAAAGTAGGGATGGGCAAAACAGCATAAGAAAATATTTTTTCTTAATGCAGATGGACAGTGTTTTCTT 4961 GTTTTAAAAATGTTTTGCCTATTTGCCAGCATTTTTTGAAGTAATACACTGCTGCTACCTGGAAGATGTCTAACTTCATT 5041 TTCTACAACTCTTATGTGATTTTGCCATTGTCATTAAGATGCATTGATTTTATTTATGAGGTGTATGACTTTAAATATCT 5121 AAATGCTGTATTAAGTGACTTGTTTCAAAGGAATAAATGAAGTGAAAACGT Target sites
Provided by authors
Predicted by miRanda
DRVs
SNPs
DRVs & SNPs
|
||||||||||||||||||||
miRNA-target interactions (Predicted by miRanda) |
|
||||||||||||||||||||
DRVs in gene 3'UTRs | |||||||||||||||||||||
SNPs in gene 3'UTRs |
Experimental Support 1 for Functional miRNA-Target Interaction | |||||||
---|---|---|---|---|---|---|---|
miRNA:Target | ---- | ||||||
Validation Method |
|
||||||
Conditions | HEK293 | ||||||
Location of target site | 3'UTR | ||||||
Tools used in this research | TargetScan , miRTarCLIP , Piranha | ||||||
Original Description (Extracted from the article) |
...
PAR-CLIP data was present in GSM545212. RNA binding protein: AGO1. Condition:Control
PAR-CLIP data was present in GSM545216. RNA binding protein: AGO2. Condition:miR-124 transfection
... - Hafner M; Landthaler M; Burger L; Khorshid et al., 2010, Cell. |
||||||
miRNA-target interactions (Provided by authors) |
|
||||||
Article |
- Hafner M; Landthaler M; Burger L; Khorshid et al. - Cell, 2010
RNA transcripts are subject to posttranscriptional gene regulation involving hundreds of RNA-binding proteins (RBPs) and microRNA-containing ribonucleoprotein complexes (miRNPs) expressed in a cell-type dependent fashion. We developed a cell-based crosslinking approach to determine at high resolution and transcriptome-wide the binding sites of cellular RBPs and miRNPs. The crosslinked sites are revealed by thymidine to cytidine transitions in the cDNAs prepared from immunopurified RNPs of 4-thiouridine-treated cells. We determined the binding sites and regulatory consequences for several intensely studied RBPs and miRNPs, including PUM2, QKI, IGF2BP1-3, AGO/EIF2C1-4 and TNRC6A-C. Our study revealed that these factors bind thousands of sites containing defined sequence motifs and have distinct preferences for exonic versus intronic or coding versus untranslated transcript regions. The precise mapping of binding sites across the transcriptome will be critical to the interpretation of the rapidly emerging data on genetic variation between individuals and how these variations contribute to complex genetic diseases.
LinkOut: [PMID: 20371350]
|
Experimental Support 2 for Functional miRNA-Target Interaction | |
---|---|
miRNA:Target | ---- |
Validation Method |
|
Conditions | HEK293 |
Disease | 55432.0 |
Location of target site | 3'UTR |
Tools used in this research | TargetScan , miRTarCLIP , Piranha |
Original Description (Extracted from the article) |
...
"PAR-CLIP data was present in GSM714645. RNA binding protein: AGO2. Condition:completeT1
... - Kishore S; Jaskiewicz L; Burger L; Hausser et al., 2011, Nature methods. |
Article |
- Kishore S; Jaskiewicz L; Burger L; Hausser et al. - Nature methods, 2011
Cross-linking and immunoprecipitation (CLIP) is increasingly used to map transcriptome-wide binding sites of RNA-binding proteins. We developed a method for CLIP data analysis, and applied it to compare CLIP with photoactivatable ribonucleoside-enhanced CLIP (PAR-CLIP) and to uncover how differences in cross-linking and ribonuclease digestion affect the identified sites. We found only small differences in accuracies of these methods in identifying binding sites of HuR, which binds low-complexity sequences, and Argonaute 2, which has a complex binding specificity. We found that cross-link-induced mutations led to single-nucleotide resolution for both PAR-CLIP and CLIP. Our results confirm the expectation from original CLIP publications that RNA-binding proteins do not protect their binding sites sufficiently under the denaturing conditions used during the CLIP procedure, and we show that extensive digestion with sequence-specific RNases strongly biases the recovered binding sites. This bias can be substantially reduced by milder nuclease digestion conditions.
LinkOut: [PMID: 21572407]
|
Experimental Support 3 for Functional miRNA-Target Interaction | |
---|---|
miRNA:Target | ---- |
Validation Method |
|
Conditions | HEK293 |
Disease | 55432.0 |
Location of target site | 3'UTR |
Tools used in this research | TargetScan , miRTarCLIP , Piranha |
Original Description (Extracted from the article) |
...
"PAR-CLIP data was present in GSM1065667. RNA binding protein: AGO1. Condition:4-thiouridine
... - Memczak S; Jens M; Elefsinioti A; Torti F; et al., 2013, Nature. |
Article |
- Memczak S; Jens M; Elefsinioti A; Torti F; et al. - Nature, 2013
Circular RNAs (circRNAs) in animals are an enigmatic class of RNA with unknown function. To explore circRNAs systematically, we sequenced and computationally analysed human, mouse and nematode RNA. We detected thousands of well-expressed, stable circRNAs, often showing tissue/developmental-stage-specific expression. Sequence analysis indicated important regulatory functions for circRNAs. We found that a human circRNA, antisense to the cerebellar degeneration-related protein 1 transcript (CDR1as), is densely bound by microRNA (miRNA) effector complexes and harbours 63 conserved binding sites for the ancient miRNA miR-7. Further analyses indicated that CDR1as functions to bind miR-7 in neuronal tissues. Human CDR1as expression in zebrafish impaired midbrain development, similar to knocking down miR-7, suggesting that CDR1as is a miRNA antagonist with a miRNA-binding capacity ten times higher than any other known transcript. Together, our data provide evidence that circRNAs form a large class of post-transcriptional regulators. Numerous circRNAs form by head-to-tail splicing of exons, suggesting previously unrecognized regulatory potential of coding sequences.
LinkOut: [PMID: 23446348]
|
CLIP-seq Support 1 for dataset GSM545212 | |
---|---|
Method / RBP | PAR-CLIP / AGO1 |
Cell line / Condition | HEK293 / Control |
Location of target site | ENST00000315927.4 | 3UTR | CUACCUCACACAUCC |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Article / Accession Series | PMID: 20371350 / GSE21578 |
CLIP-seq Viewer | Link |
CLIP-seq Support 2 for dataset GSM545216 | |
---|---|
Method / RBP | PAR-CLIP / AGO2 |
Cell line / Condition | HEK293 / miR-124 transfection |
Location of target site | ENST00000315927.4 | 3UTR | UACUACCUCACACAUCCAG |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Article / Accession Series | PMID: 20371350 / GSE21578 |
CLIP-seq Viewer | Link |
CLIP-seq Support 3 for dataset GSM714645 | |
---|---|
Method / RBP | PAR-CLIP / AGO2 |
Cell line / Condition | HEK293 / completeT1, repB |
Location of target site | ENST00000315927.4 | 3UTR | UACUACCUCACACAUCCAG |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Article / Accession Series | PMID: 21572407 / GSE28865 |
CLIP-seq Viewer | Link |
CLIP-seq Support 4 for dataset GSM1065667 | |
---|---|
Method / RBP | PAR-CLIP / AGO1 |
Cell line / Condition | HEK293 / 4-thiouridine, ML_MM_6 |
Location of target site | ENST00000315927.4 | 3UTR | AGGGUUGAAGCCUACUACCUCACACAUCCAGA |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Article / Accession Series | PMID: 23446348 / GSE43573 |
CLIP-seq Viewer | Link |
MiRNA-Target Expression Profile | |||||||
---|---|---|---|---|---|---|---|
|
MiRNA-Target Expression Profile (TCGA) | |||||||
---|---|---|---|---|---|---|---|
|
140 hsa-miR-6818-5p Target Genes:
Functional analysis:
ID![]() |
Target | Description | Validation methods |
![]() |
![]() |
|||||||
Strong evidence | Less strong evidence | |||||||||||
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
|||||
MIRT071796 | RNF11 | ring finger protein 11 | ![]() |
![]() |
2 | 2 | ||||||
MIRT077120 | NKIRAS2 | NFKB inhibitor interacting Ras like 2 | ![]() |
![]() |
2 | 4 | ||||||
MIRT079951 | RNF138 | ring finger protein 138 | ![]() |
![]() |
2 | 2 | ||||||
MIRT102968 | EN2 | engrailed homeobox 2 | ![]() |
![]() |
2 | 4 | ||||||
MIRT115694 | MGRN1 | mahogunin ring finger 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT121074 | FGFRL1 | fibroblast growth factor receptor like 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT143171 | GLYR1 | glyoxylate reductase 1 homolog | ![]() |
![]() |
2 | 2 | ||||||
MIRT145635 | LASP1 | LIM and SH3 protein 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT282026 | ARID3B | AT-rich interaction domain 3B | ![]() |
![]() |
2 | 6 | ||||||
MIRT301684 | EP300 | E1A binding protein p300 | ![]() |
![]() |
2 | 2 | ||||||
MIRT328627 | AKIRIN1 | akirin 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT340977 | IPO5 | importin 5 | ![]() |
![]() |
2 | 2 | ||||||
MIRT371401 | STC2 | stanniocalcin 2 | ![]() |
![]() |
2 | 2 | ||||||
MIRT378008 | TMED7 | transmembrane p24 trafficking protein 7 | ![]() |
![]() |
2 | 4 | ||||||
MIRT445185 | CCDC88C | coiled-coil domain containing 88C | ![]() |
![]() |
2 | 2 | ||||||
MIRT447120 | DUSP16 | dual specificity phosphatase 16 | ![]() |
![]() |
2 | 2 | ||||||
MIRT449153 | SORCS2 | sortilin related VPS10 domain containing receptor 2 | ![]() |
![]() |
2 | 2 | ||||||
MIRT450200 | ABHD15 | abhydrolase domain containing 15 | ![]() |
![]() |
2 | 2 | ||||||
MIRT453853 | ZNF12 | zinc finger protein 12 | ![]() |
![]() |
2 | 2 | ||||||
MIRT459077 | LSM1 | LSM1 homolog, mRNA degradation associated | ![]() |
![]() |
2 | 2 | ||||||
MIRT461304 | MRPS27 | mitochondrial ribosomal protein S27 | ![]() |
![]() |
2 | 2 | ||||||
MIRT464137 | VPS28 | VPS28, ESCRT-I subunit | ![]() |
![]() |
2 | 2 | ||||||
MIRT468114 | SH3PXD2A | SH3 and PX domains 2A | ![]() |
![]() |
2 | 2 | ||||||
MIRT471401 | PDP2 | pyruvate dehyrogenase phosphatase catalytic subunit 2 | ![]() |
![]() |
2 | 2 | ||||||
MIRT478220 | DDX52 | DExD-box helicase 52 | ![]() |
![]() |
2 | 2 | ||||||
MIRT479695 | CCNT1 | cyclin T1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT479779 | CCND1 | cyclin D1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT484980 | UBE2V1 | ubiquitin conjugating enzyme E2 V1 | ![]() |
![]() |
2 | 8 | ||||||
MIRT485016 | TMEM189-UBE2V1 | TMEM189-UBE2V1 readthrough | ![]() |
![]() |
2 | 8 | ||||||
MIRT485034 | TMEM189 | transmembrane protein 189 | ![]() |
![]() |
2 | 8 | ||||||
MIRT485221 | PRICKLE1 | prickle planar cell polarity protein 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT490143 | TERF2IP | TERF2 interacting protein | ![]() |
![]() |
2 | 6 | ||||||
MIRT508908 | DOK6 | docking protein 6 | ![]() |
![]() |
2 | 6 | ||||||
MIRT513877 | HNRNPUL1 | heterogeneous nuclear ribonucleoprotein U like 1 | ![]() |
![]() |
2 | 4 | ||||||
MIRT515966 | C9orf156 | tRNA methyltransferase O | ![]() |
![]() |
2 | 4 | ||||||
MIRT517892 | CHAF1B | chromatin assembly factor 1 subunit B | ![]() |
![]() |
2 | 4 | ||||||
MIRT518660 | CLVS2 | clavesin 2 | ![]() |
![]() |
2 | 4 | ||||||
MIRT520027 | YOD1 | YOD1 deubiquitinase | ![]() |
![]() |
2 | 6 | ||||||
MIRT523884 | EPHA5 | EPH receptor A5 | ![]() |
![]() |
2 | 4 | ||||||
MIRT529237 | PORCN | porcupine O-acyltransferase | ![]() |
![]() |
2 | 2 | ||||||
MIRT535337 | PFN1 | profilin 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT537532 | EZR | ezrin | ![]() |
![]() |
2 | 2 | ||||||
MIRT537695 | ELOVL6 | ELOVL fatty acid elongase 6 | ![]() |
![]() |
2 | 2 | ||||||
MIRT538494 | CLOCK | clock circadian regulator | ![]() |
![]() |
2 | 2 | ||||||
MIRT539140 | ARHGAP35 | Rho GTPase activating protein 35 | ![]() |
![]() |
2 | 2 | ||||||
MIRT541380 | CDKN1A | cyclin dependent kinase inhibitor 1A | ![]() |
![]() |
2 | 2 | ||||||
MIRT545018 | PLP1 | proteolipid protein 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT547732 | KIF23 | kinesin family member 23 | ![]() |
![]() |
2 | 4 | ||||||
MIRT548257 | FBXL20 | F-box and leucine rich repeat protein 20 | ![]() |
![]() |
2 | 2 | ||||||
MIRT550372 | MYLK3 | myosin light chain kinase 3 | ![]() |
![]() |
2 | 2 | ||||||
MIRT551867 | TMEM47 | transmembrane protein 47 | ![]() |
![]() |
2 | 2 | ||||||
MIRT552289 | SNAP29 | synaptosome associated protein 29 | ![]() |
![]() |
2 | 2 | ||||||
MIRT552902 | VSNL1 | visinin like 1 | ![]() |
![]() |
2 | 8 | ||||||
MIRT552990 | VAMP4 | vesicle associated membrane protein 4 | ![]() |
![]() |
2 | 4 | ||||||
MIRT554729 | RHOC | ras homolog family member C | ![]() |
![]() |
2 | 2 | ||||||
MIRT555301 | PPP3CB | protein phosphatase 3 catalytic subunit beta | ![]() |
![]() |
2 | 2 | ||||||
MIRT556832 | KATNAL1 | katanin catalytic subunit A1 like 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT557523 | GPBP1L1 | GC-rich promoter binding protein 1 like 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT558238 | EDA2R | ectodysplasin A2 receptor | ![]() |
![]() |
2 | 2 | ||||||
MIRT558920 | CBX1 | chromobox 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT559198 | BLOC1S6 | biogenesis of lysosomal organelles complex 1 subunit 6 | ![]() |
![]() |
2 | 2 | ||||||
MIRT559611 | AMER1 | APC membrane recruitment protein 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT559769 | URGCP-MRPS24 | URGCP-MRPS24 readthrough | ![]() |
![]() |
2 | 4 | ||||||
MIRT564648 | ZNF487P | zinc finger protein 487 | ![]() |
1 | 1 | |||||||
MIRT565856 | NHS | NHS actin remodeling regulator | ![]() |
![]() |
2 | 2 | ||||||
MIRT569044 | ZNF655 | zinc finger protein 655 | ![]() |
![]() |
2 | 2 | ||||||
MIRT569154 | SIGMAR1 | sigma non-opioid intracellular receptor 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT569166 | DMD | dystrophin | ![]() |
![]() |
2 | 2 | ||||||
MIRT569205 | CASZ1 | castor zinc finger 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT569264 | BRWD3 | bromodomain and WD repeat domain containing 3 | ![]() |
![]() |
2 | 2 | ||||||
MIRT569431 | FLVCR1 | feline leukemia virus subgroup C cellular receptor 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT569476 | CTSE | cathepsin E | ![]() |
![]() |
2 | 2 | ||||||
MIRT570232 | NCAN | neurocan | ![]() |
![]() |
2 | 2 | ||||||
MIRT570519 | SHH | sonic hedgehog | ![]() |
![]() |
2 | 2 | ||||||
MIRT570680 | FZD5 | frizzled class receptor 5 | ![]() |
![]() |
2 | 2 | ||||||
MIRT572161 | CRK | CRK proto-oncogene, adaptor protein | ![]() |
![]() |
2 | 2 | ||||||
MIRT575142 | Cd93 | CD93 antigen | ![]() |
![]() |
2 | 3 | ||||||
MIRT575644 | Mitf | microphthalmia-associated transcription factor | ![]() |
![]() |
2 | 3 | ||||||
MIRT575653 | Synpo | synaptopodin | ![]() |
![]() |
2 | 4 | ||||||
MIRT576375 | Runx1t1 | runt-related transcription factor 1; translocated to, 1 (cyclin D-related) | ![]() |
![]() |
2 | 2 | ||||||
MIRT576388 | Fhl2 | four and a half LIM domains 2 | ![]() |
![]() |
2 | 3 | ||||||
MIRT576413 | Pla2g16 | phospholipase A2, group XVI | ![]() |
![]() |
2 | 2 | ||||||
MIRT576697 | Hps3 | HPS3, biogenesis of lysosomal organelles complex 2 subunit 1 | ![]() |
![]() |
2 | 3 | ||||||
MIRT606872 | CHST11 | carbohydrate sulfotransferase 11 | ![]() |
![]() |
2 | 4 | ||||||
MIRT606940 | GFRA1 | GDNF family receptor alpha 1 | ![]() |
![]() |
2 | 6 | ||||||
MIRT607025 | ZEB1 | zinc finger E-box binding homeobox 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT607028 | PPY | pancreatic polypeptide | ![]() |
![]() |
2 | 4 | ||||||
MIRT607081 | MITF | melanogenesis associated transcription factor | ![]() |
![]() |
2 | 3 | ||||||
MIRT607769 | HS6ST3 | heparan sulfate 6-O-sulfotransferase 3 | ![]() |
![]() |
2 | 6 | ||||||
MIRT607881 | SATB1 | SATB homeobox 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT607996 | BTBD9 | BTB domain containing 9 | ![]() |
![]() |
2 | 2 | ||||||
MIRT608124 | TSC22D2 | TSC22 domain family member 2 | ![]() |
![]() |
2 | 2 | ||||||
MIRT608132 | TGFBR2 | transforming growth factor beta receptor 2 | ![]() |
![]() |
2 | 2 | ||||||
MIRT608209 | ADAT2 | adenosine deaminase, tRNA specific 2 | ![]() |
![]() |
2 | 2 | ||||||
MIRT608337 | SPN | sialophorin | ![]() |
![]() |
2 | 2 | ||||||
MIRT608416 | SYNPO | synaptopodin | ![]() |
![]() |
2 | 5 | ||||||
MIRT608459 | CD93 | CD93 molecule | ![]() |
![]() |
2 | 3 | ||||||
MIRT608555 | SBK1 | SH3 domain binding kinase 1 | ![]() |
![]() |
2 | 6 | ||||||
MIRT608585 | PPP2R1B | protein phosphatase 2 scaffold subunit Abeta | ![]() |
![]() |
2 | 4 | ||||||
MIRT608785 | JAKMIP2 | janus kinase and microtubule interacting protein 2 | ![]() |
![]() |
2 | 4 | ||||||
MIRT608791 | CDH12 | cadherin 12 | ![]() |
![]() |
2 | 2 | ||||||
MIRT608816 | ONECUT3 | one cut homeobox 3 | ![]() |
![]() |
2 | 6 | ||||||
MIRT608876 | CNTF | ciliary neurotrophic factor | ![]() |
![]() |
2 | 6 | ||||||
MIRT608881 | CLIC6 | chloride intracellular channel 6 | ![]() |
![]() |
2 | 2 | ||||||
MIRT608894 | ZNF860 | zinc finger protein 860 | ![]() |
![]() |
2 | 2 | ||||||
MIRT608954 | GIMAP1 | GTPase, IMAP family member 1 | ![]() |
![]() |
2 | 4 | ||||||
MIRT609007 | HPS3 | HPS3, biogenesis of lysosomal organelles complex 2 subunit 1 | ![]() |
![]() |
2 | 3 | ||||||
MIRT609045 | INVS | inversin | ![]() |
![]() |
2 | 4 | ||||||
MIRT619037 | CASS4 | Cas scaffolding protein family member 4 | ![]() |
![]() |
2 | 2 | ||||||
MIRT625226 | RPSAP58 | ribosomal protein SA pseudogene 58 | ![]() |
![]() |
2 | 4 | ||||||
MIRT625545 | GABRB2 | gamma-aminobutyric acid type A receptor beta2 subunit | ![]() |
![]() |
2 | 2 | ||||||
MIRT627333 | TTLL7 | tubulin tyrosine ligase like 7 | ![]() |
![]() |
2 | 2 | ||||||
MIRT627954 | NLK | nemo like kinase | ![]() |
![]() |
2 | 2 | ||||||
MIRT629280 | UNC13A | unc-13 homolog A | ![]() |
![]() |
2 | 2 | ||||||
MIRT634982 | TNFAIP8 | TNF alpha induced protein 8 | ![]() |
![]() |
2 | 2 | ||||||
MIRT646129 | C1orf147 | chromosome 1 open reading frame 147 | ![]() |
![]() |
2 | 2 | ||||||
MIRT646370 | SLC22A6 | solute carrier family 22 member 6 | ![]() |
![]() |
2 | 2 | ||||||
MIRT652743 | TGFA | transforming growth factor alpha | ![]() |
![]() |
2 | 4 | ||||||
MIRT653984 | SEMA6A | semaphorin 6A | ![]() |
![]() |
2 | 2 | ||||||
MIRT660038 | C15orf61 | chromosome 15 open reading frame 61 | ![]() |
![]() |
2 | 2 | ||||||
MIRT663504 | NKAPL | NFKB activating protein like | ![]() |
![]() |
2 | 4 | ||||||
MIRT667117 | OCIAD2 | OCIA domain containing 2 | ![]() |
![]() |
2 | 2 | ||||||
MIRT683747 | C3orf36 | chromosome 3 open reading frame 36 | ![]() |
![]() |
2 | 2 | ||||||
MIRT683922 | SLC43A3 | solute carrier family 43 member 3 | ![]() |
![]() |
2 | 2 | ||||||
MIRT684101 | LHFP | LHFPL tetraspan subfamily member 6 | ![]() |
![]() |
2 | 2 | ||||||
MIRT684224 | FGF14 | fibroblast growth factor 14 | ![]() |
![]() |
2 | 2 | ||||||
MIRT685560 | SRD5A3 | steroid 5 alpha-reductase 3 | ![]() |
![]() |
2 | 2 | ||||||
MIRT687408 | NRXN1 | neurexin 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT687467 | NHSL2 | NHS like 2 | ![]() |
![]() |
2 | 2 | ||||||
MIRT687695 | LEPREL1 | prolyl 3-hydroxylase 2 | ![]() |
1 | 1 | |||||||
MIRT688094 | GLRA3 | glycine receptor alpha 3 | ![]() |
![]() |
2 | 2 | ||||||
MIRT688255 | FHL2 | four and a half LIM domains 2 | ![]() |
![]() |
2 | 3 | ||||||
MIRT688851 | CAMKK2 | calcium/calmodulin dependent protein kinase kinase 2 | ![]() |
![]() |
2 | 2 | ||||||
MIRT700293 | RABGEF1 | RAB guanine nucleotide exchange factor 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT704679 | CHST2 | carbohydrate sulfotransferase 2 | ![]() |
![]() |
2 | 2 | ||||||
MIRT706392 | PPID | peptidylprolyl isomerase D | ![]() |
![]() |
2 | 2 | ||||||
MIRT707388 | SLC35F6 | solute carrier family 35 member F6 | ![]() |
![]() |
2 | 2 | ||||||
MIRT707509 | PPP1R16B | protein phosphatase 1 regulatory subunit 16B | ![]() |
![]() |
2 | 2 | ||||||
MIRT709808 | AR | androgen receptor | ![]() |
![]() |
2 | 2 | ||||||
MIRT715491 | MAZ | MYC associated zinc finger protein | ![]() |
![]() |
2 | 2 |
miRNA-Drug Resistance Associations | ||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|